Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss

Summary Proton magnetic resonance spectroscopy (MRS) and MRI were carried out in II patients with multiple sclerosis who had clinical evidence of severe cerebellar involvement, 11 multiple sclerosis patients (of similar age and disease duration) who had minimal or no signs of cerebellar disease. eig...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain (London, England : 1878) England : 1878), 1995-12, Vol.118 (6), p.1583-1592
Hauptverfasser: Davie, C. A., Barker, G. J., Webb, S., Tofts, P. S., Thompson, A. J., Harding, A. E., McDonald, W. I., Miller, D. H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1592
container_issue 6
container_start_page 1583
container_title Brain (London, England : 1878)
container_volume 118
creator Davie, C. A.
Barker, G. J.
Webb, S.
Tofts, P. S.
Thompson, A. J.
Harding, A. E.
McDonald, W. I.
Miller, D. H.
description Summary Proton magnetic resonance spectroscopy (MRS) and MRI were carried out in II patients with multiple sclerosis who had clinical evidence of severe cerebellar involvement, 11 multiple sclerosis patients (of similar age and disease duration) who had minimal or no signs of cerebellar disease. eight patients with autosomal dominant cerebellar ataxia (ADCA) and 11 healthy controls. In all subjects MRS was localized to cerebellar white matter (volumes of interest 3–6 ml). Apparent metabolite concentrations were calculated using the fully relaxed water spectrum as an internal standard of reference. The patients also underwent MRI to assess cerebellar volume and (in the two multiple sclerosis groups) lesion volume within the posterior fossa. Magnetic resonance spectroscopy from cerebellar white matter showed a highly significant reduction in the concentration of N-acetyl groups (NA) [which consists predominantly of N-acetylaspartate (NAA), a neuronal marker] in the multiple sclerosis group with cerebellar deficit compared with the multiple sclerosis group with minimal or no signs of cerebellar involvement, and healthy controls. Follow-up MRS performed in six of the multiple sclerosis patients 9 months later showed no change in the median NA concentration. The ADCA group showed a significant reduction of NA from a region of cerebellar white matter and also a reduction in the concentration of choline-containing compounds. The multiple sclerosis group with severe cerebellar deficit and the ADCA group both had significant cerebellar atrophy (suggesting nerve cell body and axon loss) compared with the multiple sclerosis patients with minimal or no signs of cerebellar deficit and healthy controls. The multiple sclerosis patients with cerebellar deficit had a significantly greater lesion volume in the posterior fossa, although the proportion of the spectroscopic voxel occupied by lesions was small, suggesting that axonal loss from normal appearing white matter also contributes to the observed reduction in NA. These results support the hypothesis that axonal loss is important in the development of persistent clinical disability in multiple sclerosis
doi_str_mv 10.1093/brain/118.6.1583
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77802279</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20618034</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-32caf37f927099ffab2766e5e813cc30a146fba6db11fc51a0e597c39cf55393</originalsourceid><addsrcrecordid>eNqF0jFv1DAUB_AIgcpR2FmQLIS65fpsx3Yyogpa1EogdANisV58tnBJ4sN2xPXb1-FON7B08vB-78l-f1fVWwprCh2_7CP66ZLSdi3XVLT8WbWijYSaUSGfVysAkHXbCXhZvUrpHoA2nMmz6qwVnWhataoevtmYfMp2ysTNk8k-TDiQrXXe-Ez8RMZ5yH43WJLMYGMomOC0JTjnkMK42DD6CUu_sdH2dhgwEsy490gWm1IwHrPdkr8-_yK4DxMZQkqvqxcOh2TfHM_zavP50-bqpr77ev3l6uNdbRoBuebMoOPKdUxB1zmHPVNSWmFbyo3hgOW9rke57Sl1RlAEKzpleGecELzj59XFYewuhj-zTVmPPpnllpMNc9JKtcCYehoykLQF3jwJqYKmFUoV-P4_eB_mWNZbTFk_UxSgIDggU3abonV6F_2I8UFT0EvG-l_GumSspV4yLi3vjnPnfrTbU8Mx1FL_cKxjMji4iJPx6cRY-Q9CssLqA1vi35_KGH9rqbgS-ubHTy2-89vrDW_1LX8EBJLA2A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>195427100</pqid></control><display><type>article</type><title>Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss</title><source>MEDLINE</source><source>Oxford Journals A-Z Collection</source><creator>Davie, C. A. ; Barker, G. J. ; Webb, S. ; Tofts, P. S. ; Thompson, A. J. ; Harding, A. E. ; McDonald, W. I. ; Miller, D. H.</creator><creatorcontrib>Davie, C. A. ; Barker, G. J. ; Webb, S. ; Tofts, P. S. ; Thompson, A. J. ; Harding, A. E. ; McDonald, W. I. ; Miller, D. H.</creatorcontrib><description>Summary Proton magnetic resonance spectroscopy (MRS) and MRI were carried out in II patients with multiple sclerosis who had clinical evidence of severe cerebellar involvement, 11 multiple sclerosis patients (of similar age and disease duration) who had minimal or no signs of cerebellar disease. eight patients with autosomal dominant cerebellar ataxia (ADCA) and 11 healthy controls. In all subjects MRS was localized to cerebellar white matter (volumes of interest 3–6 ml). Apparent metabolite concentrations were calculated using the fully relaxed water spectrum as an internal standard of reference. The patients also underwent MRI to assess cerebellar volume and (in the two multiple sclerosis groups) lesion volume within the posterior fossa. Magnetic resonance spectroscopy from cerebellar white matter showed a highly significant reduction in the concentration of N-acetyl groups (NA) [which consists predominantly of N-acetylaspartate (NAA), a neuronal marker] in the multiple sclerosis group with cerebellar deficit compared with the multiple sclerosis group with minimal or no signs of cerebellar involvement, and healthy controls. Follow-up MRS performed in six of the multiple sclerosis patients 9 months later showed no change in the median NA concentration. The ADCA group showed a significant reduction of NA from a region of cerebellar white matter and also a reduction in the concentration of choline-containing compounds. The multiple sclerosis group with severe cerebellar deficit and the ADCA group both had significant cerebellar atrophy (suggesting nerve cell body and axon loss) compared with the multiple sclerosis patients with minimal or no signs of cerebellar deficit and healthy controls. The multiple sclerosis patients with cerebellar deficit had a significantly greater lesion volume in the posterior fossa, although the proportion of the spectroscopic voxel occupied by lesions was small, suggesting that axonal loss from normal appearing white matter also contributes to the observed reduction in NA. These results support the hypothesis that axonal loss is important in the development of persistent clinical disability in multiple sclerosis</description><identifier>ISSN: 0006-8950</identifier><identifier>EISSN: 1460-2156</identifier><identifier>DOI: 10.1093/brain/118.6.1583</identifier><identifier>PMID: 8595487</identifier><identifier>CODEN: BRAIAK</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adult ; Aged ; Aspartic Acid - analogs &amp; derivatives ; Aspartic Acid - metabolism ; Axons - ultrastructure ; Biological and medical sciences ; Cerebellar Ataxia - genetics ; Cerebellar Ataxia - pathology ; Cerebellar Ataxia - physiopathology ; Cerebellum - metabolism ; Cerebellum - pathology ; Genes, Dominant ; hereditary ataxia ; Humans ; Magnetic Resonance Imaging ; Magnetic Resonance Spectroscopy ; Medical sciences ; Middle Aged ; MRS spectroscopy ; multiple sclerosis ; Multiple Sclerosis - diagnosis ; Multiple Sclerosis - pathology ; Multiple Sclerosis - physiopathology ; Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis ; N-acetyl aspartate ; Neurology</subject><ispartof>Brain (London, England : 1878), 1995-12, Vol.118 (6), p.1583-1592</ispartof><rights>1996 INIST-CNRS</rights><rights>Copyright Oxford University Press(England) Dec 1995</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-32caf37f927099ffab2766e5e813cc30a146fba6db11fc51a0e597c39cf55393</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2950562$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8595487$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Davie, C. A.</creatorcontrib><creatorcontrib>Barker, G. J.</creatorcontrib><creatorcontrib>Webb, S.</creatorcontrib><creatorcontrib>Tofts, P. S.</creatorcontrib><creatorcontrib>Thompson, A. J.</creatorcontrib><creatorcontrib>Harding, A. E.</creatorcontrib><creatorcontrib>McDonald, W. I.</creatorcontrib><creatorcontrib>Miller, D. H.</creatorcontrib><title>Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss</title><title>Brain (London, England : 1878)</title><addtitle>Brain</addtitle><description>Summary Proton magnetic resonance spectroscopy (MRS) and MRI were carried out in II patients with multiple sclerosis who had clinical evidence of severe cerebellar involvement, 11 multiple sclerosis patients (of similar age and disease duration) who had minimal or no signs of cerebellar disease. eight patients with autosomal dominant cerebellar ataxia (ADCA) and 11 healthy controls. In all subjects MRS was localized to cerebellar white matter (volumes of interest 3–6 ml). Apparent metabolite concentrations were calculated using the fully relaxed water spectrum as an internal standard of reference. The patients also underwent MRI to assess cerebellar volume and (in the two multiple sclerosis groups) lesion volume within the posterior fossa. Magnetic resonance spectroscopy from cerebellar white matter showed a highly significant reduction in the concentration of N-acetyl groups (NA) [which consists predominantly of N-acetylaspartate (NAA), a neuronal marker] in the multiple sclerosis group with cerebellar deficit compared with the multiple sclerosis group with minimal or no signs of cerebellar involvement, and healthy controls. Follow-up MRS performed in six of the multiple sclerosis patients 9 months later showed no change in the median NA concentration. The ADCA group showed a significant reduction of NA from a region of cerebellar white matter and also a reduction in the concentration of choline-containing compounds. The multiple sclerosis group with severe cerebellar deficit and the ADCA group both had significant cerebellar atrophy (suggesting nerve cell body and axon loss) compared with the multiple sclerosis patients with minimal or no signs of cerebellar deficit and healthy controls. The multiple sclerosis patients with cerebellar deficit had a significantly greater lesion volume in the posterior fossa, although the proportion of the spectroscopic voxel occupied by lesions was small, suggesting that axonal loss from normal appearing white matter also contributes to the observed reduction in NA. These results support the hypothesis that axonal loss is important in the development of persistent clinical disability in multiple sclerosis</description><subject>Adult</subject><subject>Aged</subject><subject>Aspartic Acid - analogs &amp; derivatives</subject><subject>Aspartic Acid - metabolism</subject><subject>Axons - ultrastructure</subject><subject>Biological and medical sciences</subject><subject>Cerebellar Ataxia - genetics</subject><subject>Cerebellar Ataxia - pathology</subject><subject>Cerebellar Ataxia - physiopathology</subject><subject>Cerebellum - metabolism</subject><subject>Cerebellum - pathology</subject><subject>Genes, Dominant</subject><subject>hereditary ataxia</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>MRS spectroscopy</subject><subject>multiple sclerosis</subject><subject>Multiple Sclerosis - diagnosis</subject><subject>Multiple Sclerosis - pathology</subject><subject>Multiple Sclerosis - physiopathology</subject><subject>Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis</subject><subject>N-acetyl aspartate</subject><subject>Neurology</subject><issn>0006-8950</issn><issn>1460-2156</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0jFv1DAUB_AIgcpR2FmQLIS65fpsx3Yyogpa1EogdANisV58tnBJ4sN2xPXb1-FON7B08vB-78l-f1fVWwprCh2_7CP66ZLSdi3XVLT8WbWijYSaUSGfVysAkHXbCXhZvUrpHoA2nMmz6qwVnWhataoevtmYfMp2ysTNk8k-TDiQrXXe-Ez8RMZ5yH43WJLMYGMomOC0JTjnkMK42DD6CUu_sdH2dhgwEsy490gWm1IwHrPdkr8-_yK4DxMZQkqvqxcOh2TfHM_zavP50-bqpr77ev3l6uNdbRoBuebMoOPKdUxB1zmHPVNSWmFbyo3hgOW9rke57Sl1RlAEKzpleGecELzj59XFYewuhj-zTVmPPpnllpMNc9JKtcCYehoykLQF3jwJqYKmFUoV-P4_eB_mWNZbTFk_UxSgIDggU3abonV6F_2I8UFT0EvG-l_GumSspV4yLi3vjnPnfrTbU8Mx1FL_cKxjMji4iJPx6cRY-Q9CssLqA1vi35_KGH9rqbgS-ubHTy2-89vrDW_1LX8EBJLA2A</recordid><startdate>19951201</startdate><enddate>19951201</enddate><creator>Davie, C. A.</creator><creator>Barker, G. J.</creator><creator>Webb, S.</creator><creator>Tofts, P. S.</creator><creator>Thompson, A. J.</creator><creator>Harding, A. E.</creator><creator>McDonald, W. I.</creator><creator>Miller, D. H.</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19951201</creationdate><title>Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss</title><author>Davie, C. A. ; Barker, G. J. ; Webb, S. ; Tofts, P. S. ; Thompson, A. J. ; Harding, A. E. ; McDonald, W. I. ; Miller, D. H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-32caf37f927099ffab2766e5e813cc30a146fba6db11fc51a0e597c39cf55393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aspartic Acid - analogs &amp; derivatives</topic><topic>Aspartic Acid - metabolism</topic><topic>Axons - ultrastructure</topic><topic>Biological and medical sciences</topic><topic>Cerebellar Ataxia - genetics</topic><topic>Cerebellar Ataxia - pathology</topic><topic>Cerebellar Ataxia - physiopathology</topic><topic>Cerebellum - metabolism</topic><topic>Cerebellum - pathology</topic><topic>Genes, Dominant</topic><topic>hereditary ataxia</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>MRS spectroscopy</topic><topic>multiple sclerosis</topic><topic>Multiple Sclerosis - diagnosis</topic><topic>Multiple Sclerosis - pathology</topic><topic>Multiple Sclerosis - physiopathology</topic><topic>Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis</topic><topic>N-acetyl aspartate</topic><topic>Neurology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Davie, C. A.</creatorcontrib><creatorcontrib>Barker, G. J.</creatorcontrib><creatorcontrib>Webb, S.</creatorcontrib><creatorcontrib>Tofts, P. S.</creatorcontrib><creatorcontrib>Thompson, A. J.</creatorcontrib><creatorcontrib>Harding, A. E.</creatorcontrib><creatorcontrib>McDonald, W. I.</creatorcontrib><creatorcontrib>Miller, D. H.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Brain (London, England : 1878)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Davie, C. A.</au><au>Barker, G. J.</au><au>Webb, S.</au><au>Tofts, P. S.</au><au>Thompson, A. J.</au><au>Harding, A. E.</au><au>McDonald, W. I.</au><au>Miller, D. H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss</atitle><jtitle>Brain (London, England : 1878)</jtitle><addtitle>Brain</addtitle><date>1995-12-01</date><risdate>1995</risdate><volume>118</volume><issue>6</issue><spage>1583</spage><epage>1592</epage><pages>1583-1592</pages><issn>0006-8950</issn><eissn>1460-2156</eissn><coden>BRAIAK</coden><abstract>Summary Proton magnetic resonance spectroscopy (MRS) and MRI were carried out in II patients with multiple sclerosis who had clinical evidence of severe cerebellar involvement, 11 multiple sclerosis patients (of similar age and disease duration) who had minimal or no signs of cerebellar disease. eight patients with autosomal dominant cerebellar ataxia (ADCA) and 11 healthy controls. In all subjects MRS was localized to cerebellar white matter (volumes of interest 3–6 ml). Apparent metabolite concentrations were calculated using the fully relaxed water spectrum as an internal standard of reference. The patients also underwent MRI to assess cerebellar volume and (in the two multiple sclerosis groups) lesion volume within the posterior fossa. Magnetic resonance spectroscopy from cerebellar white matter showed a highly significant reduction in the concentration of N-acetyl groups (NA) [which consists predominantly of N-acetylaspartate (NAA), a neuronal marker] in the multiple sclerosis group with cerebellar deficit compared with the multiple sclerosis group with minimal or no signs of cerebellar involvement, and healthy controls. Follow-up MRS performed in six of the multiple sclerosis patients 9 months later showed no change in the median NA concentration. The ADCA group showed a significant reduction of NA from a region of cerebellar white matter and also a reduction in the concentration of choline-containing compounds. The multiple sclerosis group with severe cerebellar deficit and the ADCA group both had significant cerebellar atrophy (suggesting nerve cell body and axon loss) compared with the multiple sclerosis patients with minimal or no signs of cerebellar deficit and healthy controls. The multiple sclerosis patients with cerebellar deficit had a significantly greater lesion volume in the posterior fossa, although the proportion of the spectroscopic voxel occupied by lesions was small, suggesting that axonal loss from normal appearing white matter also contributes to the observed reduction in NA. These results support the hypothesis that axonal loss is important in the development of persistent clinical disability in multiple sclerosis</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>8595487</pmid><doi>10.1093/brain/118.6.1583</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-8950
ispartof Brain (London, England : 1878), 1995-12, Vol.118 (6), p.1583-1592
issn 0006-8950
1460-2156
language eng
recordid cdi_proquest_miscellaneous_77802279
source MEDLINE; Oxford Journals A-Z Collection
subjects Adult
Aged
Aspartic Acid - analogs & derivatives
Aspartic Acid - metabolism
Axons - ultrastructure
Biological and medical sciences
Cerebellar Ataxia - genetics
Cerebellar Ataxia - pathology
Cerebellar Ataxia - physiopathology
Cerebellum - metabolism
Cerebellum - pathology
Genes, Dominant
hereditary ataxia
Humans
Magnetic Resonance Imaging
Magnetic Resonance Spectroscopy
Medical sciences
Middle Aged
MRS spectroscopy
multiple sclerosis
Multiple Sclerosis - diagnosis
Multiple Sclerosis - pathology
Multiple Sclerosis - physiopathology
Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis
N-acetyl aspartate
Neurology
title Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T17%3A44%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Persistent%20functional%20deficit%20in%20multiple%20sclerosis%20and%20autosomal%20dominant%20cerebellar%20ataxia%20is%20associated%20with%20axon%20loss&rft.jtitle=Brain%20(London,%20England%20:%201878)&rft.au=Davie,%20C.%20A.&rft.date=1995-12-01&rft.volume=118&rft.issue=6&rft.spage=1583&rft.epage=1592&rft.pages=1583-1592&rft.issn=0006-8950&rft.eissn=1460-2156&rft.coden=BRAIAK&rft_id=info:doi/10.1093/brain/118.6.1583&rft_dat=%3Cproquest_cross%3E20618034%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=195427100&rft_id=info:pmid/8595487&rfr_iscdi=true